A Trimeric, V2-Deleted HIV-1 Envelope Glycoprotein Vaccine Elicits Potent Neutralizing Antibodies but Limited Breadth of Neutralization in Human VolunteersPaul Spearman, Michelle Lally, Marnie Elizaga et al.|The Journal of Infectious Diseases|2011Cited by 79
Pharmacokinetics and Safety of Tenofovir in HIV-Infected Women During Labor and Their Infants During the First Week of LifeMark Mirochnick, Lynne Mofenson, Esaú João et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2013Cited by 67
Bone Age and Mineral Density Assessments Using Plain Roentgenograms in Tenofovir-exposed Infants in Malawi and Brazil Enrolled in HIV Prevention Trials Network 057L. Osório, Karin Nielsen‐Saines, M. Ines Boechat et al.|The Pediatric Infectious Disease Journal|2016Cited by 5